Saakshi Medtech and Panels Limited reported a significant surge in financial performance for the financial year ended March 31, 2026, with net profit rising 161% to ₹1228.97 crore. The company’s revenue from operations increased to ₹11550.64 crore, up from ₹9243.11 crore in the previous year, driven by growth in its manufacturing segment. The Board of Directors approved the audited standalone financial results during its meeting held on May 26, 2026, following recommendations from the Audit Committee.

The statutory auditors, M/s. Kishor Gujar and Associates, issued an audit report with an unmodified opinion on the financial results. The auditors confirmed that the results present a true and fair view in conformity with the recognition and measurement principles laid down in Accounting Standard (AS) 25. The company operates in a single business segment, Manufacturing, and is exempt from adopting Indian Accounting Standards (IndAS) as it is listed on an SME Exchange.

Total income for the year stood at ₹11604.44 crore, compared to ₹9300.33 crore in FY25. The company managed its expenses effectively, with total expenses for the year at ₹9937.73 crore, up from ₹8641.48 crore in the prior year. Profit before tax for the year ended March 31, 2026, was ₹1666.71 crore, a significant increase from ₹658.85 crore in the previous year. The basic and diluted earnings per share (EPS) for the year were recorded at ₹6.96, compared to ₹2.67 in FY25.

The company’s balance sheet reflects a strengthening of its asset base. Total assets increased to ₹15698.63 crore as of March 31, 2026, from ₹13133.37 crore in the previous year. Shareholders' funds grew to ₹11033.44 crore, driven by an increase in reserves and surplus to ₹9267.84 crore. Non-current assets, primarily comprising property, plant, and equipment, stood at ₹9566.62 crore, while current assets were recorded at ₹6132.02 crore.

Cash flow from operating activities improved to ₹1758.36 crore for the year, compared to ₹302.26 crore in FY25. However, the company invested heavily in expanding its asset base, resulting in a net cash outflow of ₹2534.11 crore from investing activities. Cash and cash equivalents at the end of the year stood at ₹179.61 crore. The Board confirmed that there were no exceptional or extraordinary items during the reporting period and that no investor complaints were pending or received during the year.

Financial Results for FY26

Saakshi Medtech and Panels Limited has informed the exchanges regarding the resignation of Mr. Vishvas Vinayak Palande from its Board of Directors. The resignation is effective from May 20, 2026. Mr. Palande, who served as a Non-Executive Independent Director, cited an increase in occupancy in his professional commitments and personal reasons as the basis for his decision.

Following his resignation, Mr. Palande has ceased to be a member of key board committees. He is no longer part of the Audit Committee, the Nomination & Remuneration Committee, the Stakeholder Relationship Committee, and the Corporate Social Responsibility Committee of the company.

The Board has placed on record its appreciation for the valuable contribution and guidance provided by Mr. Palande during his tenure. He confirmed that there are no material reasons for his resignation other than those disclosed in his resignation letter.

Resignation Details

The company provided specific disclosures regarding the cessation of the directorship in its regulatory filing.